MRSN
Price
$7.75
Change
-$0.36 (-4.44%)
Updated
Aug 22 closing price
Capitalization
38.68M
80 days until earnings call
SLXN
Price
$7.18
Change
+$0.38 (+5.59%)
Updated
Aug 22 closing price
Capitalization
5.25M
Interact to see
Advertisement

MRSN vs SLXN

Header iconMRSN vs SLXN Comparison
Open Charts MRSN vs SLXNBanner chart's image
Mersana Therapeutics
Price$7.75
Change-$0.36 (-4.44%)
Volume$71.86K
Capitalization38.68M
Silexion Therapeutics
Price$7.18
Change+$0.38 (+5.59%)
Volume$26.38K
Capitalization5.25M
MRSN vs SLXN Comparison Chart in %
Loading...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRSN vs. SLXN commentary
Aug 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSN is a Hold and SLXN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 24, 2025
Stock price -- (MRSN: $7.75 vs. SLXN: $7.18)
Brand notoriety: MRSN and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRSN: 30% vs. SLXN: 29%
Market capitalization -- MRSN: $38.68M vs. SLXN: $5.25M
MRSN [@Biotechnology] is valued at $38.68M. SLXN’s [@Biotechnology] market capitalization is $5.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRSN’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • MRSN’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, both MRSN and SLXN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRSN’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • MRSN’s TA Score: 5 bullish, 4 bearish.
  • SLXN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MRSN is a better buy in the short-term than SLXN.

Price Growth

MRSN (@Biotechnology) experienced а +8.24% price change this week, while SLXN (@Biotechnology) price change was -0.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.57%. For the same industry, the average monthly price growth was +18.06%, and the average quarterly price growth was +26.94%.

Reported Earning Dates

MRSN is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRSN($38.7M) has a higher market cap than SLXN($5.25M). SLXN (-76.186) and MRSN (-78.322) have similar YTD gains . SLXN has higher annual earnings (EBITDA): -17.81M vs. MRSN (-68.88M). MRSN has more cash in the bank: 77M vs. SLXN (3.47M). SLXN has less debt than MRSN: SLXN (3.7M) vs MRSN (20.6M). MRSN has higher revenues than SLXN: MRSN (34.8M) vs SLXN (0).
MRSNSLXNMRSN / SLXN
Capitalization38.7M5.25M737%
EBITDA-68.88M-17.81M387%
Gain YTD-78.322-76.186103%
P/E RatioN/AN/A-
Revenue34.8M0-
Total Cash77M3.47M2,222%
Total Debt20.6M3.7M557%
FUNDAMENTALS RATINGS
MRSN: Fundamental Ratings
MRSN
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRSNSLXN
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
40%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
22%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
20%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 27 days ago
51%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 3 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
50%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QXO20.391.57
+8.34%
QXO Inc
ACNB46.592.49
+5.65%
ACNB Corp
RIME2.030.03
+1.50%
Algorhythm Holdings Inc
VITL50.940.75
+1.49%
Vital Farms
SGA13.300.10
+0.76%
Saga Communications

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with IMA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
-4.44%
IMA - MRSN
65%
Loosely correlated
+1.07%
CELC - MRSN
62%
Loosely correlated
+4.05%
IGMS - MRSN
54%
Loosely correlated
N/A
CRNX - MRSN
48%
Loosely correlated
+5.17%
DYN - MRSN
45%
Loosely correlated
+2.95%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+5.59%
IMA - SLXN
63%
Loosely correlated
+1.07%
CELC - SLXN
50%
Loosely correlated
+4.05%
MRSN - SLXN
43%
Loosely correlated
-4.44%
CHRS - SLXN
26%
Poorly correlated
+8.85%
QSI - SLXN
25%
Poorly correlated
+2.70%
More